Altium Capital Management LP has filed its 13F form on February 13, 2025 for Q4 2024 where it was disclosed a total value porftolio of $301 Million distributed in 67 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Adma Biologics, Inc. with a value of $23.9M, Vera Therapeutics, Inc. with a value of $18.3M, Sarepta Therapeutics, Inc. with a value of $15.4M, Establishment Labs Holdings Inc. with a value of $14.1M, and Edwards Lifesciences Corp with a value of $12.2M.

Examining the 13F form we can see an increase of $17.5M in the current position value, from $283M to 301M.

Altium Capital Management LP is based out at New York, NY

Below you can find more details about Altium Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $301 Million
Healthcare: $300 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 67
  • Current Value $301 Million
  • Prior Value $283 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 13, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 19 stocks
  • Additional Purchases 18 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 17 stocks
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.